|
Medtronic Defibrillator Leads
Medtronic Inc. has removed its Sprint
Fidelis defibrillation leads from the market after five patient deaths have been
linked to the devices. Medtronic said that the defibrillator lead can fracture
and may have been a contributing factor in the deaths. A fracture in the
defibrillator lead can cause a defibrillator to deliver unnecessary shocks to
the heart or not operate at all.
Defibrillators are used to regulate a
persons heartbeat. The device can sense an abnormal heart rhythm and then
deliver an electronic shock to reset the heart to a normal beat. A
defibrillation system consists of a device implanted near the shoulder with one
or more leads connecting the device to the heart. Medtronic has begun asking
doctors to stop implanting the leads and return all unused leads to Medtronic.
The Following Medtronic Sprint Fidelis Leads were recalled:
-
Sprint Fidelis 6930
-
Sprint Fidelis 6931
-
Sprint Fidelis 6948
-
Sprint Fidelis 6949
On October 14, 2007,
Medtronic, the nation's largest heart implant device manufacturer, announced
a defect in the critical electrical "lead" component of its heart
defibrillator. The
New York Times reported on October
15, 2007, that the defect in this electrical wire, called the Sprint Fidelis,
has resulted in hundreds of malfunctions and may have played a role in the
death of five Medtronic defibrillator patients.
Contact Us
If you have any questions concerning this case please feel free to
contact
Stacey Tjon at 701-237-3166 or
toll-free 877-237-3166 or by e-mail at:
stjon@solberglaw.com |
